Redwood Shores, Calif.-based
Model N, Inc.
, a leading revenue management solutions provider to the life science and technology industries, opened for trading today on the
New York Stock Exchange
(NYSE) under the ticker symbol “
” after its initial public offering. GETCO Securities LLC is the Designated Market Maker for the company’s stock.
Founder, Chairman and CEO Zack Rinat, accompanied by members of Model N’s leadership team, commemorated the company’s first day of trading by ringing the NYSE Opening Bell
and visiting the trading floor to witness the stock opening.
“Becoming a publicly traded company on the NYSE is recognition that Revenue Management software is a proven source of competitive advantage for companies in the life sciences and the technology industries. Furthermore it is a testament to our customers, partners, and employees daring to pioneer a new software category,” said Zack Rinat, Founder, Chairman, and CEO of Model N.
“We are delighted to welcome Model N to the NYSE’s growing community of technology companies,” said Scott R. Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “Model N is a leader in revenue management solutions offering life science and technology companies around the globe a suite of innovative tools and services to support their distinctive business needs. We congratulate Model N on its first day as a publicly-traded company and look forward to sharing a long and fruitful partnership with Model N and its shareholders.”
For more information on NYSE Euronext’s listings business and to learn about trends in the IPO market, please visit the
NYSE Euronext IPO Center
: Model N, Inc. Founder, Chairman and CEO Zack Rinat (center, blue tie), joined by members of the company’s leadership team, rings the NYSE Opening Bell
to celebrate Model N’s IPO and first day of trading on the NYSE.
: Model N, Inc. Founder Chairman and CEO Zack Rinat in the center of the trading crowd (dark blue suit, blue tie) as the company’s stock begins trading on the NYSE.
About Model N
Model N, a leading provider of Revenue Management Solutions, drives improved pricing, margin, and revenue performance through a powerful combination of best practices, highly configurable software applications, comprehensive services, and actionable analytics across the complete functional spectrum of pricing, contracting, rebating, sales, and marketing. Model N leverages its deep industry expertise to support the unique business needs of Life Sciences and Technology companies across more than 50 countries. Global Customers include: Allergan, Amgen, Atmel, Boston Scientific, Bristol-Myers Squibb, Dell, Johnson & Johnson, Linear Technology, Merck, Marvell, Maxim, Micron, Nokia, Novartis, Novo Nordisk, ON Semiconductor, STMicroelectronics, and Watson Pharmaceuticals. Whether you are an emerging business or a global leader, Model N results in revenue.
Model N Press Center
Model N Investor Relations